%0 Journal Article %T Cardiac phenotype in ATP1A3-related syndromes: A multicenter cohort study. %A Balestrini S %A Mikati MA %A Álvarez-García-Rovés R %A Carboni M %A Hunanyan AS %A Kherallah B %A McLean M %A Prange L %A De Grandis E %A Gagliardi A %A Pisciotta L %A Stagnaro M %A Veneselli E %A Campistol J %A Fons C %A Pias-Peleteiro L %A Brashear A %A Miller C %A Samões R %A Brankovic V %A Padiath QS %A Potic A %A Pilch J %A Vezyroglou A %A Bye AME %A Davis AM %A Ryan MM %A Semsarian C %A Hollingsworth G %A Scheffer IE %A Granata T %A Nardocci N %A Ragona F %A Arzimanoglou A %A Panagiotakaki E %A Carrilho I %A Zucca C %A Novy J %A Dzieżyc K %A Parowicz M %A Mazurkiewicz-Bełdzińska M %A Weckhuysen S %A Pons R %A Groppa S %A Sinden DS %A Pitt GS %A Tinker A %A Ashworth M %A Michalak Z %A Thom M %A Cross JH %A Vavassori R %A Kaski JP %A Sisodiya SM %J Neurology %V 95 %N 21 %D 11 2020 24 %M 32913013 %F 11.8 %R 10.1212/WNL.0000000000010794 %X To define the risks and consequences of cardiac abnormalities in ATP1A3-related syndromes.
Patients meeting clinical diagnostic criteria for rapid-onset dystonia-parkinsonism (RDP), alternating hemiplegia of childhood (AHC), and cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss (CAPOS) with ATP1A3 genetic analysis and at least 1 cardiac assessment were included. We evaluated the cardiac phenotype in an Atp1a3 knock-in mouse (Mashl+/-) to determine the sequence of events in seizure-related cardiac death.
Ninety-eight patients with AHC, 9 with RDP, and 3 with CAPOS (63 female, mean age 17 years) were included. Resting ECG abnormalities were found in 52 of 87 (60%) with AHC, 2 of 3 (67%) with CAPOS, and 6 of 9 (67%) with RDP. Serial ECGs showed dynamic changes in 10 of 18 patients with AHC. The first Holter ECG was abnormal in 24 of 65 (37%) cases with AHC and RDP with either repolarization or conduction abnormalities. Echocardiography was normal. Cardiac intervention was required in 3 of 98 (≈3%) patients with AHC. In the mouse model, resting ECGs showed intracardiac conduction delay; during induced seizures, heart block or complete sinus arrest led to death.
We found increased prevalence of ECG dynamic abnormalities in all ATP1A3-related syndromes, with a risk of life-threatening cardiac rhythm abnormalities equivalent to that in established cardiac channelopathies (≈3%). Sudden cardiac death due to conduction abnormality emerged as a seizure-related outcome in murine Atp1a3-related disease. ATP1A3-related syndromes are cardiac diseases and neurologic diseases. We provide guidance to identify patients potentially at higher risk of sudden cardiac death who may benefit from insertion of a pacemaker or implantable cardioverter-defibrillator.